Britt Meelby Jensen was labeled "the biotech queen": "Unfortunately, I think it demonstrates how there are still few female top executives in Denmark"
Atos Medical CEO Britt Meelby Jensen works hard and is curious about her projects, qualities which have brought her to the top of the life science industry – a place few women have gone before.
BY MARIA OIEN, TRANSLATED BY CATHERINE BRETT AND DANIEL PEDERSEN
When Britt Meelby Jensen started as CEO at Zealand Pharma in March 2015, she was dubbed "the new biotech queen" by the media. However, the executive was not happy about the title – not because of challenges she experiences as a woman in her everyday life, but because it shows that society still has a long way to go, she says.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
